Project description
A novel vaccine 'train' carries a diversely qualified team to the station
Vaccines are currently being made by tacking a natural antigen – a component of the offending microbe recognised by the immune system – onto a carrier protein. While this method has achieved significant gains in the realm of public health, the vaccines are rather limited in scope/function, and the current large protein molecule formulations have limited stability and shelf life. Sort of like a building manager with a lot of keys on their key ring, the EU-funded SUPRAVACC project's synthetic multipotent vaccines will carry multiple different immunostimulants and antigens. Their stability will get a boost from the reliance on small molecules rather than large delicate proteins. In short, the technology could revolutionise vaccine scope and vaccination speed and efficacy.
Fields of science
Programme(s)
Funding Scheme
ERC-COG - Consolidator Grant
Host institution
55122 Mainz
Germany
See on map
Beneficiaries (2)
55122 Mainz
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
55131 Mainz
See on map